Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | CDKN2A |
| Variant | R80* |
| Impact List | nonsense |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | CDKN2A R80* results in a premature truncation of the Cdkn2a protein at amino acid 80 of 156 (UniProt.org). R80* results in loss of Cdk binding in an in vitro assay (PMID: 8668202), and therefore, is predicted to lead to a loss of Cdkn2a protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
CDKN2A mutant CDKN2A inact mut CDKN2A R80* |
| Transcript | NM_000077.5 |
| gDNA | chr9:g.21971121G>A |
| cDNA | c.238C>T |
| Protein | p.R80* |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_011517676.2 | chr9:g.21971121G>A | c.238C>T | p.R80* | RefSeq | GRCh38/hg38 |
| XM_047422598.1 | chr9:g.21970966_21970968delCGCinsTGA | c.238_240delCGCinsTGA | p.R80* | RefSeq | GRCh38/hg38 |
| XM_011517675.2 | chr9:g.21971121G>A | c.238C>T | p.R80* | RefSeq | GRCh38/hg38 |
| XM_011517676.3 | chr9:g.21971121G>A | c.238C>T | p.R80* | RefSeq | GRCh38/hg38 |
| XM_011517675.3 | chr9:g.21971121G>A | c.238C>T | p.R80* | RefSeq | GRCh38/hg38 |
| NM_001195132 | chr9:g.21971121G>A | c.238C>T | p.R80* | RefSeq | GRCh38/hg38 |
| XM_011517679 | chr9:g.21970966_21970968delGCGinsTCA | c.238_240delCGCinsTGA | p.R80* | RefSeq | GRCh38/hg38 |
| NM_001363763.2 | chr9:g.21970966_21970968delCGCinsTGA | c.238_240delCGCinsTGA | p.R80* | RefSeq | GRCh38/hg38 |
| XM_047422596.1 | chr9:g.21970966_21970968delCGCinsTGA | c.238_240delCGCinsTGA | p.R80* | RefSeq | GRCh38/hg38 |
| XM_011517675 | chr9:g.21971121G>A | c.238C>T | p.R80* | RefSeq | GRCh38/hg38 |
| NM_000077 | chr9:g.21971121G>A | c.238C>T | p.R80* | RefSeq | GRCh38/hg38 |
| XM_011517676 | chr9:g.21971121G>A | c.238C>T | p.R80* | RefSeq | GRCh38/hg38 |
| XM_011517679.1 | chr9:g.21970966_21970968delCGCinsTGA | c.238_240delCGCinsTGA | p.R80* | RefSeq | GRCh38/hg38 |
| NM_001195132.2 | chr9:g.21971121G>A | c.238C>T | p.R80* | RefSeq | GRCh38/hg38 |
| XM_005251343 | chr9:g.21970966_21970968delGCGinsTCA | c.238_240delCGCinsTGA | p.R80* | RefSeq | GRCh38/hg38 |
| NM_000077.4 | chr9:g.21971121G>A | c.238C>T | p.R80* | RefSeq | GRCh38/hg38 |
| XM_005251343.1 | chr9:g.21970966_21970968delCGCinsTGA | c.238_240delCGCinsTGA | p.R80* | RefSeq | GRCh38/hg38 |
| NM_000077.5 | chr9:g.21971121G>A | c.238C>T | p.R80* | RefSeq | GRCh38/hg38 |
| NM_001195132.1 | chr9:g.21971121G>A | c.238C>T | p.R80* | RefSeq | GRCh38/hg38 |
| XM_047422597.1 | chr9:g.21970966_21970968delCGCinsTGA | c.238_240delCGCinsTGA | p.R80* | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|